|
000
| 02414cam 22003858i 4500 |
|---|
| 001 | 9.904714 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107180628 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 211108s2021 oncbd o f000 0 eng d |
|---|
| 020 | |a9780660408583 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-299/2021E-PDF |
|---|
| 245 | 00|aHow has COVID-19 impacted the delivery of STBBI-related services, including harm reduction services, in Canada? |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2021] |
|---|
| 300 | |a1 online resource (1 unnumbered page) : |bmaps, charts |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |aIssued also in French under title: Quelles sont les répercussions de la COVID-19 sur la prestation des services liés aux infections transmissibles sexuellement et par le sang (ITSS), y compris les services de réduction des méfaits, au Canada? |
|---|
| 520 | |a"The Public Health Agency of Canada conducted an online survey in November and December 2020 to better understand how the COVID-19 pandemic has affected the ability of healthcare service providers to deliver sexually transmitted and blood-borne infection (STBBI) prevention, testing and treatment services, including harm reduction and drug treatment services, in Canada"--Page [1]. |
|---|
| 650 | 0|aSexually transmitted diseases|zCanada|xPrevention. |
|---|
| 650 | 0|aBloodborne infections|zCanada|xPrevention. |
|---|
| 650 | 0|aCOVID-19 (Disease)|zCanada. |
|---|
| 650 | 0|aCOVID-19 Pandemic, 2020-|xHealth aspects|zCanada. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tQuelles sont les répercussions de la COVID-19 sur la prestation des services liés aux infections transmissibles sexuellement et par le sang (ITSS), y compris les services de réduction des méfaits, au Canada? |w(CaOODSP)9.904715 |
|---|
| 856 | 40|qPDF|s406 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-299-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment-infographic.html |
|---|